NICOLE THOMAS: Open Payments
NPI 1457994113 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| Corcept Therapeutics | 2 | $33 |
| Exeltis, USA Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: UBRELVY, Korlym, SLYND, Veozah, RECORLEV, Ozempic, QULIPTA, ELIQUIS.
Industry payments across ID — which companies pay providers there.
